Intraday Stock's Future Recommendation Report - 27 SEP 2013
Subscribe to get Recommendation link on your email ID and know what to do
Download recommendations for 27 SEP 2013:click here
Initial Investment Required: 1,50,000 INR
Intraday Individual Stock's Future Trading Strategy
On 26 SEP 2013, Stock Futures entered
Not Entered
(%age calculated on stock move basis.)
On 26 SEP 2013, Stock Futures entered
-1% overall StopLoss
NOT ENTERED
Net Strategy return (%):0.00% (0.00)
Absolute Strategy Return from 17 Jan 2012(%):55.18%
(%age calculated on stock move basis.)
-1% down or +1% up
NOT ENTERED
Net Strategy return (%):0.00.% (0.00)
Absolute Strategy Return from 22 APR 2013(%):63.30%
(%age calculated on actual return basis.)
Download Archived recommendations for 26 SEP 2013
Please Read carefully Intraday Stock's Future Trading Guidelines before investing
Brokers and Sub brokers may contact us for getting our recommendation for their clients as well placing their ads on our blog page or website.
Download recommendations for 27 SEP 2013:click here
Initial Investment Required: 1,50,000 INR
Intraday Individual Stock's Future Trading Strategy
On 26 SEP 2013, Stock Futures entered
Not Entered
(%age calculated on stock move basis.)
On 26 SEP 2013, Stock Futures entered
NOT ENTERED
Net Strategy return (%):0.00% (0.00)
Absolute Strategy Return from 17 Jan 2012(%):55.18%
(%age calculated on stock move basis.)
NOT ENTERED
Net Strategy return (%):0.00.% (0.00)
Absolute Strategy Return from 22 APR 2013(%):63.30%
(%age calculated on actual return basis.)
Download Archived recommendations for 26 SEP 2013
Please Read carefully Intraday Stock's Future Trading Guidelines before investing
Brokers and Sub brokers may contact us for getting our recommendation for their clients as well placing their ads on our blog page or website.
• Alembic Pharma gets USFDA approval for Telmisartan and Amlodipine Tablets
ReplyDelete• Lupin receives USFDA nod for Losartan potassium
• Cadila receives USFDA nod for Metrodinazole tablets
CapitalStars